POM

POMDOCTOR Ltd POM

NasdaqSmall CapConsumer Discretionary

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 10 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$399.91M

Quarter to Dec 31

Net income

$-130.93M

Quarter to Dec 31

Free cash flow

$-149.49M

Quarter to Dec 31

Operating margin

-29.7%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$38.4K total
CITADEL ADVISORS LLC
$30.8K-94.2%
UBS Group AG
$5.0K-79.2%
Caitong International Asset Management Co., Ltd
$1.3K-97.2%
SRS Capital Advisors, Inc.
$1.0KNew
Steward Partners Investment Advisory, LLC
$161-94.5%
RHUMBLINE ADVISERS
$60-94.5%
See all 6 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Debt/Equity

FY 2025
EDGAR

Loading ratio trend…

POM key financials by period

Reported revenue, net income and operating margin by fiscal year, from POMDOCTOR Ltd's annual filings on SEC EDGAR.

POMDOCTOR Ltd reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$399.9M$-130.9M-29.7%
FY 2024$342.6M$-37.4M-7.5%
FY 2023$304.9M$-36.9M-7.3%
Source: POM filings on SEC EDGAR →

About POMDOCTOR Ltd (POM): stock profile, AI score and financials

POMDOCTOR Ltd (POM) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Discretionary sector company. POM is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 10 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2025), POMDOCTOR Ltd reports quarterly revenue of $399.9M, net income of $-130.9M, an operating margin of -29.7%. Top institutional holders of POM by reported 13-F value include CITADEL ADVISORS, UBS Group AG, Caitong International Asset Management , Ltd, based on the most recent SEC filings. POM trades on the Nasdaq exchange and files with the SEC under CIK 1877971. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate POM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for POMDOCTOR Ltd directly from SEC EDGAR.

SEC EDGAR: CIK 1877971 →